| CANCER & TREATMENTS SUPPORT & SURVIVORSHIP PREVENTION & RISK ASSESSMENT CLINICAL TRIALS & RESEARCH LIVING WITH CANCER | ||
Home > Cancer and Treatments > Endocrine Cancers Endocrine Oncology Program ResearchGary Hammer, M.D., Ph.D., directorThe Endocrine Oncology Program is a multidisciplinary clinical and research program focused on the genetics, endocrine cancer stem cells, pathogenesis (the process/stages of disease development) and treatment of endocrine cancers. Two multidisciplinary clinics specialize in the treatment of thyroid and adrenal tumors, respectively. Active laboratory programs include work in the areas of adrenal and thyroid cancer genetics, gene discovery, adrenal cancer metastasis, adrenal and thyroid carcinogenesis (cancer causing agents), and adrenal and thyroid cell biology. Recently, research has expanded broadly into the use of gene expression profiles as diagnostic and prognostic indicators. Endocrine Oncology Program investigators participate in a number of therapeutic trials for advanced thyroid and adrenocortical carcinoma. Biological based therapies are currently under pre-clinical and clinical development for adrenal cancer. The U-M Comprehensive Cancer Center is one of only a few centers in the country with a focused endocrine oncology program and embedded thyroid and adrenal clinics. Continue Reading about the endocrine oncology research: Adrenal Cancer Genetics The Michigan Endocrine Database (MED) The Michigan Endocrine Tissue Bank (METB). Clinical Trials Adrenal Cancer
Thyroid Cancer Research Faculty |
See Also
University of Michigan Comprehensive Cancer Center © 2009 Regents of the University of Michigan / Developed & maintained by: Public Relations & Marketing Communications. Contact Us or UMHS. The information presented is not a tool for self diagnosis or a substitute for professional care. |
||||